X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse TTK HEALTHCARE with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TTK HEALTHCARE   MYLAN
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
MYLAN
Dec-14
TTK HEALTHCARE/
MYLAN
5-Yr Chart
Click to enlarge
High Rs6634,254-   
Low Rs3992,998-   
Sales per share (Unadj.) Rs535.61,456.2-  
Earnings per share (Unadj.) Rs15.9175.4-  
Cash flow per share (Unadj.) Rs20.0282.4-  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs137.6723.9-  
Shares outstanding (eoy) m7.77378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x1.02.5 39.8%   
Avg P/E ratio x33.320.7 161.2%  
P/CF ratio (eoy) x26.512.8 206.6%  
Price / Book Value ratio x3.95.0 77.1%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m4,1271,371,817 0.3%   
No. of employees `0001.725.0 6.8%   
Total wages/salary Rs m6070-   
Avg. sales/employee Rs Th2,436.722,039.1 11.1%   
Avg. wages/employee Rs Th355.20-   
Avg. net profit/employee Rs Th72.52,655.0 2.7%   
INCOME DATA
Net Sales Rs m4,162550,976 0.8%  
Other income Rs m61-3,212 -1.9%   
Total revenues Rs m4,223547,765 0.8%   
Gross profit Rs m197137,030 0.1%  
Depreciation Rs m3240,467 0.1%   
Interest Rs m3023,766 0.1%   
Profit before tax Rs m19769,586 0.3%   
Minority Interest Rs m0-285 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m732,926 2.5%   
Profit after tax Rs m12466,374 0.2%  
Gross profit margin %4.724.9 19.0%  
Effective tax rate %37.04.2 880.1%   
Net profit margin %3.012.0 24.7%  
BALANCE SHEET DATA
Current assets Rs m1,629484,381 0.3%   
Current liabilities Rs m1,058378,689 0.3%   
Net working cap to sales %13.719.2 71.5%  
Current ratio x1.51.3 120.4%  
Inventory Days Days3078 38.1%  
Debtors Days Days34107 31.3%  
Net fixed assets Rs m556127,467 0.4%   
Share capital Rs m7819,484 0.4%   
"Free" reserves Rs m8780-   
Net worth Rs m1,069273,890 0.4%   
Long term debt Rs m159409,164 0.0%   
Total assets Rs m2,3991,103,202 0.2%  
Interest coverage x7.63.9 192.9%   
Debt to equity ratio x0.11.5 9.9%  
Sales to assets ratio x1.70.5 347.3%   
Return on assets %6.48.2 78.4%  
Return on equity %11.624.2 47.8%  
Return on capital %18.513.6 135.4%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Net fx Rs m-300-   
CASH FLOW
From Operations Rs m12772,426 0.2%  
From Investments Rs m-146-57,117 0.3%  
From Financial Activity Rs m22-19,084 -0.1%  
Net Cashflow Rs m3-3,775 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.37 Rs / USD

Compare TTK HEALTHCARE With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare TTK HEALTHCARE With: DR. DATSONS LABS  SUN PHARMA  ORCHID PHARMA LTD  VENUS REMEDIES  BIOCON LTD  



Today's Market

Where Will the Two-Faced Market Go from Here?(Podcast)

The stock markets are very volatile these days. As the Tanushree Bannerjee, the co-head of research here at Equitymaster puts it, stock markets are two-faced.

Related Views On News

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

Feb 4, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

Here's What the Biggest 'Rebirth of India' Investors are Doing(The 5 Minute Wrapup)

Feb 5, 2019

A roundtable on the 18th of January 2019 had investors with billions of dollars of investment kitty.

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Do You Have the Stomach to Survive a Small Cap Crash?(Profit Hunter)

Feb 5, 2019

While selecting good businesses is relatively easy task in a bearish phase, where most people fail is in having enough patience to hold the quality stocks until recovery.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 15, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - ABBOTT INDIA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS